Registered entities
Lysosomal Therapeutics, Inc.
Reg. No. 45-4015802United States
Innovation
16 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,401 times.
| Year | Filings |
|---|---|
| 2016 | 5 |
| 2017 | 13 |
| 2018 | 10 |
| 2019 | 14 |
| 2020 | 7 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Investor mix
13 investors on record; lead investors include Lilly Ventures, Sanofi Ventures, Atlas Venture, Hatteras Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 1 | 8% |
| Other / undisclosed | 6 | 46% |